• BH3-Mimetic Targeting of Glioblastoma Apoptotic Priming

  2026-09-28

  The study finds that glioblastoma (GBM), including stem-like tumor cells, can be unusually dependent on anti-apoptotic BCL-xL and MCL-1, revealing an apoptotic vulnerability that BH3-mimetics can exploit. Its key translational result is that sequential inhibition of these survival proteins produced strong anti-tumor responses in vivo in the tested models, supporting further investigation while leaving dose, safety, and patient-selection questions open.

• Protease Inhibitor Cocktail in Organelle Biology

  2026-09-27

  Learn how a Protease Inhibitor Cocktail EDTA-Free can protect extracted proteins while investigating MARCH5-dependent peroxisome biogenesis. This article separates post-lysis protein preservation from live-cell biology and explains practical assay choices for phosphorylation and ubiquitination studies.

• RIPostC, Ketone Bodies, and Ferroptosis After Stroke

  2026-09-26

  A 2024 study links remote ischemic postconditioning (RIPostC) to increased ketone body production and reduced ferroptosis-associated injury after experimental stroke. Its animal and cell experiments support a metabolic connection worth testing further, while leaving open which individual ketone body mediates the effects.

• Biotin-16-UTP for Testing lncRNA Translation Models

  2026-09-25

  Biotin-16-UTP enables affinity-based analysis of labeled RNA, but its value depends on asking the right mechanistic question. This article uses the LINC02870–EIF4G1–SNAIL model to show how RNA capture can complement—and must be distinguished from—evidence of altered translation.

• 3-Hydroxybutyrate in Stroke: An Assay Design Framework

  2026-09-25

  3-hydroxybutyrate (BHBA) connects ketone metabolism with cellular stress responses, but establishing its role in stroke requires more than measuring a change in ketone bodies. This article translates a remote ischemic postconditioning study into a practical framework for testing metabolite-specific causality, ferroptosis-related readouts, and experimental limitations.

• PD98059 MEK Inhibitor: Workflows & Applications

  2026-09-24

  Use PD98059 to test whether MEK–ERK signaling contributes to oxidative injury, cell-cycle changes, or apoptosis—not simply to label a pathway as active. This practical guide connects a cyclophosphamide liver-injury study to reproducible assay design, with dose-planning, controls, and troubleshooting for cell-based experiments.

• Cyclo (-RGDfC) in 96-Well Integrin Assays

  2026-09-24

  Combine the αvβ3-binding cyclic peptide c(RGDfC) with 96-well hydrogel workflows to test integrin-dependent cell behavior under controlled, reproducible conditions. The approach pairs a soluble ligand competition assay with flexible light-based substrate fabrication—without assuming the peptide itself is light-activated or validated in the printer study.

• Ceftolozane Sulfate: Assay and PK/PD Workflows

  2026-09-24

  Build a reproducible Ceftolozane sulfate workflow around broth microdilution, resistant-isolate stratification, and exposure-to-MIC analysis. The guide distinguishes what cefiderocol surveillance data can inform from what must be tested directly for Ceftolozane.

• ABT-737 BCL-2 Protein Inhibitor Workflow

  2026-09-23

  Use ABT-737 as a mechanistically defined benchmark for mitochondrial apoptosis, with practical workflows spanning lymphoma, multiple myeloma, SCLC, and AML models. Its value is amplified by pairing BCL-2 family readouts with RNA Pol II degradation-response assays that distinguish active death signaling from passive transcriptional collapse.

• ABT-263 (Navitoclax): Apoptosis Research Guide

  2026-09-22

  ABT-263, also called Navitoclax, is an orally bioavailable BCL-2-family inhibitor that engages BCL-2, BCL-XL, and BCL-W to promote mitochondrial apoptosis. This guide connects its binding profile, cancer biology applications, pediatric acute lymphoblastic leukemia evidence, formulation limits, and apoptosis assay design.

• HyperPFU™ high-fidelity DNA polymerase Guide

  2026-09-22

  HyperPFU™ high-fidelity DNA polymerase is intended for accurate amplification of long, GC-rich, inhibitor-affected, or otherwise difficult DNA templates. It produces blunt-ended PCR products for compatible cloning and sequencing workflows, but it is not the correct choice when 3′-A overhangs or preformed sticky ends are required.

• N1-Methylpseudouridine for mRNA Assay Design

  2026-09-21

  Learn how N1-Methylpseudouridine can improve mRNA translation enhancement while helping researchers separate delivery effects from innate immune and stress-response artifacts. This workflow also shows how modified mRNA assays can complement CRISPR-based studies of PCMT1, anoikis resistance, and ovarian cancer metastasis.

• Anlotinib in Desmoplastic Small Round Cell Tumor

  2026-09-21

  This case report and literature review describes the first reported clinical use of anlotinib in metastatic intra-abdominal desmoplastic small round cell tumor, with radiographic reduction of metastatic lymph nodes and manageable toxicity. Its main value is hypothesis generation: the report supports further investigation of multi-target receptor tyrosine kinase inhibition in a tumor with few standardized treatment options, while not establishing efficacy in a controlled cohort.

• BRCA1/BARD1, pre-rRNA, and Homologous Recombination

  2026-09-20

  Wu and colleagues identify pre-ribosomal RNA as a functional partner that recruits the BRCA1/BARD1 complex to DNA double-strand breaks and supports homologous recombination. Their results connect BRCT-domain recognition, RNA-driven phase separation, cancer-associated mutations, and PARP inhibitor sensitivity in a unified mechanism of genome maintenance.

• Cediranib (AZD2171): Beyond the Viability Readout

  2026-09-19

  Cediranib (AZD2171) is a potent VEGFR-pathway probe for studying angiogenesis, signaling, and tumor biology. This guide shows how to interpret pathway suppression, growth inhibition, and cell death as distinct but connected experimental outcomes.

8069 records 1/538 page Next 12345 下5页 Last page